Over the last several years, accumulating evidence suggests that reversible acetylation may be a major regulatory mechanism for controlling protein function. Recent proteomic investigations have cataloged the existence of hundreds of acetylated proteins, implicating a potential regulatory role for nearly all facets of cellular biochemistry. Interestingly, metabolic enzymes constitute the largest portion of acetylated proteins. Only in a handful of examples has the functional significance of protein acetylation been revealed. Thus, there is tremendous need to determine the regulatory functions of protein acetylation, both at the level of physiological outcomes and at the level of molecular mechanism. This proposal directly investigates the central hypothesis that reversible acetylation is a major regulatory mechanism for controlling protein function. To accomplish these goals, we will investigate the biochemical and biological functions of sirtuins, NAD+dependent protein deacetylases, which are implicated in genome maintenance, metabolism, cell survival, and lifespan.
The specific aims are focused on demonstrating a direct regulatory role for sirtuins in several major metabolic processes, and elucidating how site-specific acetylation affects enzyme function. Employing mechanistic enzymology, quantitative mass spectrometry, novel high-throughput assays, metabolic pathway analysis, structural biology, enzyme regulation, cell culture models, and mouse genetics, these studies will provide the first comprehensive understanding of the functional significance of reversible protein acetylation. The results have the potential to uncover the prominence of a previously-unknown regulatory mechanism and to transform how we understand metabolic and aged-related diseases.
New evidence suggests that a previously-unknown form of cellular and metabolic regulation exits. This proposal seeks to investigate the functional importance of this regulatory mechanism and the role played by a group of enzymes that are implicated in genome maintenance, metabolism, cell survival, and lifespan. The results have the potential to the transform how we understand metabolic and aged-related diseases, and to generate novel therapeutic opportunities.
|Baeza, Josue; Smallegan, Michael J; Denu, John M (2016) Mechanisms and Dynamics of Protein Acetylation in Mitochondria. Trends Biochem Sci 41:231-44|
|Yu, Wei; Denu, Ryan A; Krautkramer, Kimberly A et al. (2016) Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies. J Biol Chem 291:3268-79|
|Hullinger, Rikki; Li, Mi; Wang, Jingxin et al. (2016) Increased expression of AT-1/SLC33A1 causes an autistic-like phenotype in mice by affecting dendritic branching and spine formation. J Exp Med 213:1267-84|
|Kugel, Sita; Feldman, Jessica L; Klein, Mark A et al. (2015) Identification of and Molecular Basis for SIRT6 Loss-of-Function Point Mutations in Cancer. Cell Rep 13:479-88|
|Baeza, Josue; Smallegan, Michael J; Denu, John M (2015) Site-specific reactivity of nonenzymatic lysine acetylation. ACS Chem Biol 10:122-8|
|Feldman, Jessica L; Dittenhafer-Reed, Kristin E; Kudo, Norio et al. (2015) Kinetic and Structural Basis for Acyl-Group Selectivity and NAD(+) Dependence in Sirtuin-Catalyzed Deacylation. Biochemistry 54:3037-50|
|Dittenhafer-Reed, Kristin E; Richards, Alicia L; Fan, Jing et al. (2015) SIRT3 mediates multi-tissue coupling for metabolic fuel switching. Cell Metab 21:637-46|
|Sahar, Saurabh; Masubuchi, Satoru; Eckel-Mahan, Kristin et al. (2014) Circadian control of fatty acid elongation by SIRT1 protein-mediated deacetylation of acetyl-coenzyme A synthetase 1. J Biol Chem 289:6091-7|
|Baeza, Josue; Dowell, James A; Smallegan, Michael J et al. (2014) Stoichiometry of site-specific lysine acetylation in an entire proteome. J Biol Chem 289:21326-38|
|Prolla, Tomas A; Denu, John M (2014) NAD+ deficiency in age-related mitochondrial dysfunction. Cell Metab 19:178-80|
Showing the most recent 10 out of 53 publications